HELEN DOLAN: Open Payments
NPI 1104098631 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,653 in 160 payments from 36 companies in 2025. Trend: 2023 $2,999 · 2024 $2,935 · 2025 $3,653
Food & beverage: $3,654
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 23 | $648 |
| Lilly USA, LLC | 14 | $306 |
| Amgen Inc. | 11 | $263 |
| Dexcom, Inc. | 8 | $202 |
| Corcept Therapeutics | 7 | $188 |
| Radius Health, Inc. | 6 | $181 |
| Abbott Laboratories | 16 | $172 |
| ABBVIE INC. | 10 | $151 |
| Verona Pharma, Inc. | 1 | $123 |
| Tandem Diabetes Care, Inc. | 4 | $118 |
Products named: Ozempic, TEPEZZA, Dexcom G6 Transmitter, JARDIANCE, Korlym, Tymlos, FREESTYLE LIBRE 3, MOUNJARO.
Industry payments across NY — which companies pay providers there.
